Madrigal Pharmaceuticals Inc (NASDAQ:MDGL)

Delayed Data
As of Mar 21
 -1.25 / -1.07%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 4 analysts offering 12-month price forecasts for Madrigal Pharmaceuticals Inc have a median target of 153.00, with a high estimate of 170.00 and a low estimate of 140.00. The median estimate represents a +31.98% increase from the last price of 115.93.

Analyst Recommendations

The current consensus among 4 polled investment analysts is to Buy stock in Madrigal Pharmaceuticals Inc. This rating has held steady since February, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
May 11

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -13.81%
Growthannually -35.35%


Growthquarterly --
Growthannually --
Key to the earnings and sales forecast charts.